Novartis AG (SWX:NOVN)
Switzerland · Delayed Price · Currency is CHF 114.24
-0.10 (-0.09%)
Jan 22, 2026, 2:15 PM CET
Novartis AG Market Cap
Novartis AG has a market cap or net worth of 219.39 billion as of January 22, 2026. Its market cap has increased by 23.27% in one year.
Market Cap
219.39B
Enterprise Value
237.56B
Revenue
44.95B
Ranking
n/a
PE Ratio
19.65
Stock Price
114.24
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 186.69B to 219.39B, an increase of 17.52%. That is a compound annual growth rate of 0.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 219.39B | 4.32% |
| Dec 30, 2025 | 210.30B | 18.59% |
| Dec 30, 2024 | 177.34B | 1.66% |
| Dec 29, 2023 | 174.45B | -2.98% |
| Dec 30, 2022 | 179.80B | 0.12% |
| Dec 30, 2021 | 179.59B | -5.61% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 294.34B |
| Lonza Group AG | 39.15B |
| Galderma Group AG | 36.39B |
| Alcon | 31.94B |
| Sandoz Group AG | 26.70B |
| Straumann Holding AG | 15.79B |
| Sonova Holding AG | 13.19B |
| Galenica AG | 4.79B |